About Medtrum
Medtrum is a Healthcare company based in Dusseldorf (Germany) founded in 2008. Medical devices for diabetes patients are developed and produced. It operates on a HealthTech and Direct-to-Consumer (D2C) model. Medtrum has raised $28.95 million across 1 funding round from investors including BOC Investment, 5Y Capital and Sequoia Capital. Its website medtrum.com draws about 17 thousand monthly visits. Medtrum offers products and services including TouchCare ® Nano Pump, TouchCare ® Nano CGM, EasyPatch App, TouchCare ® Nano System, and TouchCare ® Slim CGM. Its focus areas include Medical Devices and Diabetes Management. Its legal entity is Medtrum Technologies Inc.
Company details
Medtrum is engaged in the development and delivery of medical devices aimed at simplifying diabetes management. The company is involved in creating tools for healthcare professionals and exploring advancements in artificial pancreas research. Solutions such as tubeless insulin pumps, continuous glucose monitors, and hybrid closed-loop systems are provided to support patients and caregivers in various countries. The healthcare sector, specifically diabetes care, is the primary focus of operations.
- Total Equity Funding$28.95M (USD)
in 1 rounds
- Latest Funding Round$28.95M (USD), Series C
Dec 2018
- InvestorsBOC Investment
& 5 more
Products & Services of Medtrum
Medtrum offers a comprehensive portfolio of products and services, including TouchCare ® Nano Pump, TouchCare ® Nano CGM, EasyPatch App, TouchCare ® Nano System, and TouchCare ® Slim CGM.
A compact tubeless insulin pump is provided for diabetes.
Continuous glucose monitoring is enabled by a small sensor.
Smartphone control for insulin pumps is facilitated through app.
Hybrid closed-loop system for automated insulin delivery is offered.
Slim continuous glucose monitor is designed for discreet use.
Apps and channels of Medtrum
Medtrum publishes 1 mobile app with over 1K+ downloads; its YouTube channel Medtrum Diabetes has 1.94K subscribers and 30 videos.
Videos from Medtrum
The most watched videos on Medtrum's YouTube channel, Medtrum Diabetes (1.94K subscribers). Click a video to play it here.
More on Medtrum Diabetes.
Funding Insights of Medtrum
Medtrum has successfully raised a total of $28.95M through 1 strategic funding round. The most recent funding activity was a Series C round of $28.95 million completed in December 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $28.95M
- Total Rounds 1
- Last Round Series C — $28.95M
- First Round $28.95M
(Dec 2018)
- Investors Count 6
All 1 funding rounds of Medtrum with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2018 | $28.95M | Series C | – | BOC Investment, Sequoia Capital China |
6 investors in total: 6 institutional.
Investors in Medtrum
Medtrum has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include BOC Investment, 5Y Capital and Sequoia Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity investments in China are managed by BOC Investment. | bocgi.com | Xicheng, China | ||
A venture capital firm focused on technology and innovation investments. | 5ycap.com | Shanghai, China | ||
A fund focused on healthcare industry investments is managed. | 2015 | 3ebiovc.cn | China | |
Venture capital firm focused on early-stage investments | sequoiacap.cn | Beijing, China | ||
Investor details for Medtrum
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Medtrum
5 people are tracked at Medtrum (2 in leadership, 3 in team).
| Name | Role | Group |
|---|---|---|
Mélanie Marmounier-Wilhelm | National Sales & Marketing Director, France | Leadership |
Jian Tu | International Sales Director | Leadership |
Tina Bohus | Regional Sales Manager | Team |
Alice Thiu Yi Chen | Assistante administratif des ventes & marketing | Team |
Nina Kornbeck Tønnesen | Regional Sales Manager | Team |
Complete people profiles for Medtrum
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Medtrum
2 dated milestones of Medtrum across 10 years, from founding to its latest funding, stage changes and deals.
- Founded Medtrum is founded.
- Funding First funding round of $29.0M.
Web traffic of Medtrum
The website of Medtrum (medtrum.com) receives about 17.3K visits a month.
- Monthly visits17.3K
▲ 11.3% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Medtrum
Medtrum was founded in 2008 and raised its 1st funding round 10 years after it was founded.
Medtrum is headquartered in Dusseldorf, Germany. It is registered at Dusseldorf, North Rhine-westphalia, Germany.
Medtrum is a funded company, having raised a total of $28.95M across 1 funding round to date. The company's 1st funding round was a Series C of $28.95M, raised on Dec 2018.
Medtrum is engaged in the development and delivery of medical devices aimed at simplifying diabetes management. The company is involved in creating tools for healthcare professionals and exploring advancements in artificial pancreas research. Solutions such as tubeless insulin pumps, continuous glucose monitors, and hybrid closed-loop systems are provided to support patients and caregivers in various countries. The healthcare sector, specifically diabetes care, is the primary focus of operations.
Medtrum offers TouchCare ® Nano Pump, TouchCare ® Nano CGM, EasyPatch App, TouchCare ® Nano System, and TouchCare ® Slim CGM.
Medtrum has 6 investors. Key investors include BOC Investment, 5Y Capital, Sequoia Capital, 3E Bioventures, and Nokai Investment.
Medtrum operates through Medtrum Technologies Inc..
Yes. Medtrum publishes Medtrum EasyPatch mmol/L, with over 1,000 downloads.